Not sure if it is sustainable, but MNKD has gone parabolic. This manufacturer of inhalable insulin has more than tripled recently. It has been on the official screen regularly since March. It actually has a 52 week low of 67 cents and is now at about $6.70.
So this one stock has almost singlehandedly enabled my most recent 4 MFI tracking portfolios to be leading the benchmark (my August tracking portfolio is already up more than 12%! Part from MNKD and part from potential tax reform).
Here is a table showing MNKD:
|Date||Stock||Initial Price||End Price||Percent Change|